HIV-1 Protease Mutations and Protease Inhibitor Cross-ResistanceSoo‐Yon Rhee, Robert W. Shafer, William Towner et al.|Antimicrobial Agents and Chemotherapy|2010Cited by 230
Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infectionCalvin Cohen, Brian P. Kearney, Richard Elion et al.|AIDS|2011Cited by 109